Synthetic method of coumarin-pyrrole compound
A synthetic method and compound technology, applied in the field of synthesis of coumarin-pyrrole compounds, can solve the problems of low utilization rate of starting materials, limited use range, harsh reaction conditions, etc., to promote deep-level expansion and not harsh storage conditions , stable effect
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Publication Date
- 2016-03-02
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical field of organic compound technology application, and specifically relates to a synthesis method of coumarin-pyrrole compounds. Background technique
[0002] Since nitrogen heterocycles are ubiquitous in natural products and medicines, they are the key areas of research. As we all know, pyrrole is a five-membered nitrogen-containing heterocyclic compound, and many drug molecules contain such a skeleton, so it is used as a basic building block in medicinal chemistry, such as formula A, a hypolipidemic drug marketed by Pfizer under the trade name Lipitor Atorvastatin (Atorvastatin) 1, lamellarin D (Lamellarin D), which is cytotoxic to many different cancer cells and has a strong inhibitory effect on human topoisomerase I60 2, non-steroidal antipyretic Anti-inflammatory drug (NSAID) Zomepirac (Zomepirac)3 and potential anticancer drug4.
[0003]
[0004] Formula A. Several drug molecules containing pyrrole struc...
Examples
Embodiment 1
[0026]
[0027] coumarins 1a (0.2mmol), disubstituted acetylene compounds 2a (0.6mmol), palladium acetate (0.02mmol) and copper acetate (0.04mmol) were added in DMSO (2mL). The reaction mixture was stirred at normal temperature and pressure under an oxygen atmosphere for 72 hours. After the completion of the reaction monitored by TLC, the organic solvent was removed by distillation under reduced pressure to obtain the crude product, and the product was obtained by flash column chromatography (ethyl acetate:n-hexane=1:4) 3aa (90%). 1 HNMR (500MHz, d 6 -DMSO,298K):δ12.80(s,1H),8.37–8.17(m,1H),7.56–7.20(m,13H). 13 CNMR (125MHz, d 6 -DMSO,298K):δ157.74,151.61,135.78,133.88,133.55,131.49,131.07,129.24,128.82,128.18,128.09,127.14,124.39,122.11,121.09,117.00,113.86,107.29,40.73,40.46,40.18,39.90, 39.62, 39.35, 39.07.HRMS(ESI): calculated value [C 23 h 15 NO 2 +H] + 338.1176, actual value 338.1177.
Embodiment 2
[0029]
[0030] The operation steps are the same as in Example 1, and the productive rate is 89%. 1 HNMR (500MHz, d 6 -DMSO,298K):δ12.72(s,1H),8.11(s,1H),7.65–7.08(m,12H),2.43(s,3H). 13 CNMR (125MHz, d 6 -DMSO,298K):δ157.87,149.80,135.82,133.73,133.61,133.49,131.48,131.06,130.09,128.80,128.70,128.13,128.10,127.14,121.91,121.06,116.77,113.52,107.32,40.73,40.46,40.18, 39.90, 39.62, 39.35, 39.07, 20.99.HRMS(ESI): calculated value [C 24 h 17 NO 2 -H] - 350.1187, the actual value is 350.1197.
Embodiment 3
[0032]
[0033] The operation steps are the same as in Example 1, and the productive rate is 99%. 1 HNMR (500MHz, d 6 -DMSO,298K):δ12.75(s,1H),8.16(s,1H),7.65–6.92(m,12H),2.74(q, J =7.6Hz,2H),1.30(t, J =7.6Hz,3H). 13 CNMR (125MHz, d 6-DMSO,298K):δ158.01,150.04,139.93,136.07,133.85,133.70,131.62,131.17,129.18,128.93,128.85,128.27,128.22,127.25,121.15,120.79,116.91,113.68,107.36,40.73,40.46,40.18, 39.90, 39.62, 39.35, 39.07, 28.18, 15.89. HRMS (ESI): calculated value [C 25 h 19 NO 2 -H] - 364.1343, actual value 364.1346.